Clinical Characterization of a Novel Oral Thrombopoietin Mimetic LGD-4665 in Healthy Volunteers Demonstrate Safe and Sustained Increases in Platelet Counts with Flexible Dosing Choices for Phase II Trials

被引:0
|
作者
Dziewanowska, Zofia E. [1 ]
Kapil, Ram P. [1 ]
Zhang, J. K. [1 ]
Berg, Jolene K. [2 ]
Stevens, Victor J. [1 ]
Matsumoto, Richard M. [1 ]
Greenberg, Lisa [1 ]
Morris, Maryanna Y. [1 ]
机构
[1] Ligand Pharmaceut, Clin Res, San Diego, CA USA
[2] CEDRA Clin Res, San Antonio, TX USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1168 / 1168
页数:1
相关论文
共 1 条
  • [1] SINGLE AND MULTIPLE ORAL DOSES OF LGD-4665, A SMALL MOLECULE THROMBOPOIETIN RECEPTOR AGONIST, INCREASE PLATELET COUNTS IN HEALTHY MALE SUBJECTS AND DEMONSTRATE POTENTIAL TO TREAT THROMBOCYTOPENIC PATIENTS
    Dziewanowska, E.
    Zhang, J.
    Kapil, P.
    Greenberg, G.
    Matsumoto, M.
    Schindler, J.
    Berg, J.
    Newberry, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 377 - 378